Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05560243 Completed - HIV Infections Clinical Trials

Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The overall goal of this feasibility study is to make adaptations to these evidence-based approaches in collaboration with PLWH and health care providers working with this population, and develop, implement, and evaluate the feasibility and scalability of a theory-based, culturally relevant tobacco cessation intervention for PLWH receiving care through the public health system in a southern town in Brazil (Londrina). This proposal will focus on the intervention development, pretesting, and feasibility testing. The primary outcome will be a 7-day point prevalence abstinence (defined as no tobacco use in the past 7 days and verified through measurement of salivary cotinine and exhaled carbon monoxide levels) at 6-month follow-up. We will also conduct detailed treatment fidelity and scalability assessments (acceptability, feasibility, potential reach and adoption, alignment with the strategic context) to inform a full-scale efficacy trial.

NCT ID: NCT05346991 Completed - Clinical trials for Tobacco Use Cessation

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Disseminating an evidence-based tobacco control intervention for School Teachers

NCT ID: NCT04768114 Completed - Smoking Cessation Clinical Trials

Implementation of Genomics in Substance Use Disorder Treatment

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

Cigarette smoking remains one of the leading causes of preventable death. Effective smoking cessation medications exist but use of these treatments is low, making it difficult for most to quit smoking. Behavioral interventions are needed to engage current smokers in the process of quitting smoking and promote the use of evidence-based cessation medications. At the same time, genetics influences one's smoking behaviors (e.g., how much they smoke, difficulty quitting) and risk of smoking-related diseases, yet these personalized factors have not been included in existing behavioral interventions. Incorporating these individualized factors into smoking cessation interventions may make them more personally engaging and thus motivating for treatment. This study will pilot test a risk communication tool that is personalized to one's genetics and will demonstrate the feasibility of a larger trial to test the effect of this personalized genetically-informed intervention on smoking cessation.

NCT ID: NCT04606797 Completed - Clinical trials for Tobacco Use Cessation

Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada

Start date: November 23, 2020
Phase: Phase 4
Study type: Interventional

This study will examine the impact of mailed distribution of free Nicotine Replacement Therapy to smokers in rural regions. Telephone numbers will be randomly selected from across Canada in order to recruit adult smokers interested in completing a smoking survey and willing to be interviewed again in 6 months time. Study participants will be asked about their smoking history and a hypothetical question: would they be interested in receiving the nicotine patches if this were to be provided to them free of charge? Participants expressing interest will be randomly assigned to one of two groups. One group will be offered the opportunity to actually receive a program of 5 weeks of the nicotine patch for free right away and the other group will not be offered the free nicotine patches. The proportions of smokers in the two groups who quit smoking by the 6-month interview will be compared. Characteristics of the participants and the municipalities in which they live will be used to explain why the nicotine patch intervention has a larger impact in some rural regions compared to others This projects seeks to determine the impact of mailed NRT intervention on increasing quit rates in rural areas. In addition, it seeks to understand the social determinants of health driving the large effects expected based on previous findings.

NCT ID: NCT04540081 Completed - Obesity Clinical Trials

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

CLOVER
Start date: October 5, 2020
Phase: N/A
Study type: Interventional

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

NCT ID: NCT04534231 Completed - Clinical trials for Tobacco Use Cessation

Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates

Start date: October 19, 2020
Phase:
Study type: Observational

One municipality with high smoking rates will be selected. A coupon for free-of-charge nicotine patches will be sent to each household. Reductions in the number of people smoking in the chosen municipality from before to after the NRT distribution will be estimated

NCT ID: NCT04311983 Completed - Clinical trials for Tobacco Use Cessation

Interventions to Help More Low-income Smokers Quit

SFH
Start date: March 31, 2020
Phase: N/A
Study type: Interventional

In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline) or expanded services (Quitline + Smoke Free Homes) to increase tobacco cessation.

NCT ID: NCT04207827 Completed - Pregnancy Related Clinical Trials

mHealth Intervention to Prevent Postpartum Smoking Relapse

RESPREMO
Start date: June 2, 2018
Phase: N/A
Study type: Interventional

This project aims to develop an adapted and enhanced mHealth couple intervention to prevent post-partum smoking relapse.

NCT ID: NCT04172623 Completed - Clinical trials for Tobacco Use Cessation

Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This study will use wearable technology to test the feasibility and efficacy of delivering a novel real-time smoking intervention to improve standard tobacco treatment.

NCT ID: NCT04020718 Completed - Clinical trials for Tobacco Use Cessation

Engagement With an Adaptive Mobile Health Smoking Cessation Intervention

Start date: January 31, 2020
Phase: Phase 4
Study type: Interventional

This is a pilot sequential multiple assignment trial (SMART) to understand the optimal timing to assess response to our smoking cessation text message intervention and to measure how adding medications alone compares to adding medications and telephone coaching for those who continue to smoke. This study aims to assess the feasibility of a SMART of a proactively offered text message intervention for smokers in primary care that compares early (4 weeks) versus late (8 weeks) assessment of treatment response and the addition of nicotine replacement therapy (NRT) alone or with telephone coaching for non-responders.